European Biotechs Enter the IPO Big League

Genmab's NASDAQ Debut Biggest of 2019

 
• By William Masters
  
New_York
The Nasdaq is the prime destination for US and European biotechs
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip